Betty Havens Prize

贝蒂·海文斯奖

• 批准号: 407871
• 负责人: Farrell Barbara
• 金额: $ 1.46万
• 依托单位: Bruyère Research Institute
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2019
• 资助国家: 加拿大
• 起止时间: 2019-07-01 至 2020-07-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=407871&lang=en
• 关键词: Betty Havens Prize

As people age, the benefits of previously safe medications can be outweighed by potential harms. Deprescribing is the planned and supervised process of reducing or stopping medications that may be causing harm, or may no longer be of benefit. Since 2013,

随着年龄的增长，以前安全药物的好处可能会被潜在的危害所抵消。取消处方是减少或停止可能造成伤害或可能不再有益的药物的有计划和监督的过程。自2013年以来，